Omeprazole Dosing for Adults
For most adult indications including GERD, heartburn, and ulcer healing, omeprazole 20 mg once daily is the standard dose, with 40 mg once daily reserved for specific conditions like active gastric ulcer, H. pylori eradication dual therapy, and pathological hypersecretory states. 1
Standard Adult Dosing by Indication
Heartburn and Symptomatic GERD
- Omeprazole 20 mg once daily for up to 4 weeks 1
- Take before meals 1
- This dose provides superior symptom relief compared to 10 mg daily or placebo 2
Erosive Esophagitis (EE) Treatment
- Omeprazole 20 mg once daily for 4-8 weeks 1
- If no response after 8 weeks, may give additional 4 weeks 1
- PPIs are more effective than H2-receptor antagonists for healing erosive esophagitis 3
Maintenance of Healed Erosive Esophagitis
- Omeprazole 20 mg once daily 1
- Controlled studies do not extend beyond 12 months 1
- For eosinophilic esophagitis specifically, omeprazole 20 mg twice daily is recommended for at least 8-12 weeks 4
Active Duodenal Ulcer
Active Benign Gastric Ulcer
- Omeprazole 40 mg once daily for 4-8 weeks 1
H. Pylori Eradication Regimens
Triple Therapy (Preferred)
- Omeprazole 20 mg + Amoxicillin 1000 mg + Clarithromycin 500 mg, all twice daily for 10 days 1
- If ulcer present at initiation, continue omeprazole 20 mg once daily for additional 18 days 1
- Standard dose omeprazole 20 mg twice daily achieves optimal acid inhibition for eradication 5
Dual Therapy (Alternative)
- Omeprazole 40 mg once daily + Clarithromycin 500 mg three times daily for 14 days 1
- If ulcer present, give additional 14 days of omeprazole 20 mg once daily 1
Bismuth Quadruple Therapy (First-Line Alternative)
- Bismuth + Tetracycline 500 mg + Metronidazole 500 mg + PPI (minimum 40 mg omeprazole equivalent) twice daily for 14 days 6, 7
- This regimen is preferred when antibiotic susceptibility is unknown 8
- Effective even with metronidazole resistance 7
Important considerations for H. pylori treatment:
- Higher-potency PPIs (esomeprazole 20-40 mg or rabeprazole 20-40 mg twice daily) may be preferred over omeprazole when available 6
- Clarithromycin-based regimens should only be used empirically in areas with low clarithromycin resistance (<15%) 7, 8
- After eradication failure, avoid previously used antibiotics 7, 8
Pathological Hypersecretory Conditions (Zollinger-Ellison Syndrome)
- Starting dose: 60 mg once daily, adjust to patient needs 1
- Doses >80 mg daily should be divided 1
- Doses up to 120 mg three times daily have been used 1
- Continue as long as clinically indicated; some patients treated continuously for >5 years 1
Stress Ulcer Prophylaxis in Critical Care
- Low-dose PPI therapy: ≤40 mg omeprazole daily 9
- Either enteral or IV routes are acceptable 9
- For IV administration in ICU patients, 40 mg bolus is as effective as 80 mg bolus + 8 mg/hr infusion for the first 12 hours 10
- However, for maintaining pH >6 for 24 hours, the higher dose regimen (80 mg bolus + 8 mg/hr) is superior 10
- Discontinue when critical illness resolves or risk factors are no longer present 9
Key Clinical Considerations
Dosing Frequency
- Twice-daily dosing is recommended for refractory symptoms despite once-daily therapy 3
- Expert consensus supports twice-daily PPI dosing for inadequate response to once-daily therapy, despite most trial data being from once-daily studies 3
- Patients failing twice-daily PPI therapy should be considered treatment failures 3
Administration
- Take before meals 1
- Antacids may be used concomitantly 1
- Capsules should be swallowed whole; if unable to swallow, may open and sprinkle on applesauce 1
Common Pitfalls
- Avoid using omeprazole in infants with uncomplicated reflux - placebo-controlled trials show no superiority over placebo for irritability 11
- Do not add nocturnal H2RA to twice-daily PPI - no evidence of improved efficacy 3
- Do not use doses higher than standard without clear indication - weak evidence for benefit 3
- Prolonged PPI use may increase risk of pneumonia, gastroenteritis, and C. difficile infection 11